Under-fire drug giant Valeant Pharmaceuticals International won't put Bausch & Lomb on the block, investor Bill Ackman told CNBC.
"It's a core asset," Ackman said. "We're only considering selling non-core assets."
On Wednesday, the activist investor and long-time Valeant stakeholder told an investor call that he expected to make back his losses on the drug company, which has had a disastrous six months, including accounting misstatements and concerns over its ties to specialty pharmacy Philidor.
Ackman's fund, Pershing Square, has lost about $1 billion on Valeant since taking a stake in March 2015. The stock closed up 3.9 percent at $35.51 on Thursday ET but is currently down more than 86 percent from an August 2015 high of $262.52 and fell as low as $26.11 last week.
Ackman joined the board in March, at the same time as the Canadian company ousted chief executive Mike Pearson.
A week earlier the company had slashed its 2016 revenue forecast and delayed filing its annual report. It had also come under fire after The New York Times reported that Valeant was among a number of drug companies that used a network of specialty pharmacies to prevent patients from switching to cheaper medications.
Before joining the board, Ackman had broached the possibility of selling the Bausch & Lomb eye-care business, telling Bloomberg on March 9 that Bausch & Lomb was a "very valuable standalone business" that Valeant could possibly sell a piece of to pay down debt.
In an interview with Reuters, he called Bausch & Lomb one of Valeant's "crown jewels."
With CNBC in the U.S., CNBC in Asia Pacific, CNBC in Europe, Middle East and Africa, CNBC World and CNBC HD , CNBC is the recognized world leader in business news and provides real-time financial market coverage and business information to approximately 371 million homes worldwide, including more than 100 million households in the United States and Canada. CNBC also provides daily business updates to 400 million households across China. The network's 15 live hours a day of business programming in North America (weekdays from 4:00 a.m. - 7:00 p.m. ET) is produced at CNBC's global headquarters in Englewood Cliffs, N.J., and includes reports from CNBC News bureaus worldwide. CNBC at night features a mix of new reality programming, CNBC's highly successful series produced exclusively for CNBC and a number of distinctive in-house documentaries.
CNBC also has a vast portfolio of digital products which deliver real-time financial market news and information across a variety of platforms. These include CNBC.com, the online destination for global business; CNBC PRO, the premium, integrated desktop/mobile service that provides real-time global market data and live access to CNBC global programming; and a suite of CNBC Mobile products including the CNBC Real-Time iPhone and iPad Apps.
Members of the media can receive more information about CNBC and its programming on the NBC Universal Media Village Web site at http://www.nbcumv.com/mediavillage/networks/cnbc/.